tetano
Editor, Senior Moderator
J Clin Virol. 2020 May 13:104433. doi: 10.1016/j.jcv.2020.104433. [Epub ahead of print]
Real-time PCR-based SARS-CoV-2 detection in Canadian Laboratories.
LeBlanc JJ[SUP]1,[/SUP][SUP]2[/SUP], Gubbay JB[SUP]3,[/SUP][SUP]4,[/SUP][SUP]5[/SUP], Li Y[SUP]6[/SUP], Needle R[SUP]7[/SUP], Arneson SR[SUP]6[/SUP], Marcino D[SUP]6[/SUP], Charest H[SUP]8[/SUP], Desnoyers G[SUP]9[/SUP], Dust K[SUP]10[/SUP], Fattouh R[SUP]11[/SUP], Garceau R[SUP]9[/SUP], German G[SUP]12[/SUP], Hatchette TF[SUP]1,[/SUP][SUP]2[/SUP], Kozak RA[SUP]3,[/SUP][SUP]13[/SUP], Krajden M[SUP]14[/SUP], Kuschak T[SUP]6[/SUP], Lang ALS[SUP]15[/SUP], Levett P[SUP]14[/SUP], Mazzulli T[SUP]3,[/SUP][SUP]16[/SUP], McDonald R[SUP]15[/SUP], Mubareka S[SUP]3,[/SUP][SUP]13[/SUP], Prystajecky N[SUP]14[/SUP], Rutherford C[SUP]17[/SUP], Smieja M[SUP]17[/SUP], Yu Y[SUP]7[/SUP], Zahariadis G[SUP]7[/SUP], Zelyas N[SUP]1,[/SUP][SUP]18[/SUP], Bastien N[SUP]6[/SUP]; COVID-19 Pandemic Diagnostics Investigation Team of the Canadian Public Health Laboratory Network (CPHLN) Respiratory Virus Working Group.
Author information
Abstract
With emergence of pandemic COVID-19, rapid and accurate diagnostic testing is essential. This study compared laboratory-developed tests (LDTs) used for the detection of SARS-CoV-2 in Canadian hospital and public health laboratories, and some commercially available real-time RT-PCR assays. Overall, analytical sensitivities were equivalent between LDTs and most commercially available methods.
Crown Copyright ? 2020 Published by Elsevier B.V.
KEYWORDS:
COVID-19; NAAT; PCR; SARS-CoV-2; coronavirus; molecular
PMID:32405254PMCID:PMC7219382DOI:10.1016/j.jcv.2020.104433
Real-time PCR-based SARS-CoV-2 detection in Canadian Laboratories.
LeBlanc JJ[SUP]1,[/SUP][SUP]2[/SUP], Gubbay JB[SUP]3,[/SUP][SUP]4,[/SUP][SUP]5[/SUP], Li Y[SUP]6[/SUP], Needle R[SUP]7[/SUP], Arneson SR[SUP]6[/SUP], Marcino D[SUP]6[/SUP], Charest H[SUP]8[/SUP], Desnoyers G[SUP]9[/SUP], Dust K[SUP]10[/SUP], Fattouh R[SUP]11[/SUP], Garceau R[SUP]9[/SUP], German G[SUP]12[/SUP], Hatchette TF[SUP]1,[/SUP][SUP]2[/SUP], Kozak RA[SUP]3,[/SUP][SUP]13[/SUP], Krajden M[SUP]14[/SUP], Kuschak T[SUP]6[/SUP], Lang ALS[SUP]15[/SUP], Levett P[SUP]14[/SUP], Mazzulli T[SUP]3,[/SUP][SUP]16[/SUP], McDonald R[SUP]15[/SUP], Mubareka S[SUP]3,[/SUP][SUP]13[/SUP], Prystajecky N[SUP]14[/SUP], Rutherford C[SUP]17[/SUP], Smieja M[SUP]17[/SUP], Yu Y[SUP]7[/SUP], Zahariadis G[SUP]7[/SUP], Zelyas N[SUP]1,[/SUP][SUP]18[/SUP], Bastien N[SUP]6[/SUP]; COVID-19 Pandemic Diagnostics Investigation Team of the Canadian Public Health Laboratory Network (CPHLN) Respiratory Virus Working Group.
Author information
Abstract
With emergence of pandemic COVID-19, rapid and accurate diagnostic testing is essential. This study compared laboratory-developed tests (LDTs) used for the detection of SARS-CoV-2 in Canadian hospital and public health laboratories, and some commercially available real-time RT-PCR assays. Overall, analytical sensitivities were equivalent between LDTs and most commercially available methods.
Crown Copyright ? 2020 Published by Elsevier B.V.
KEYWORDS:
COVID-19; NAAT; PCR; SARS-CoV-2; coronavirus; molecular
PMID:32405254PMCID:PMC7219382DOI:10.1016/j.jcv.2020.104433